Amanta Healthcare Limited is a pharmaceutical company engaged in the development, manufacturing, and marketing of sterile liquid products. The company specializes in parenteral products packaged in plastic containers using advanced Aseptic Blow-Fill-Seal (“ABFS”) and Injection Stretch Blow Moulding (“ISBM”) technologies. Along with pharmaceuticals, Amanta also operates in the medical devices segment.
The company’s portfolio includes fluid therapy formulations such as intravenous (IV) fluids, diluents, ophthalmic solutions, and respiratory care products. Additionally, it offers irrigation solutions, first-aid products, and eye lubricants under its medical device business.
Amanta Healthcare operates through three business verticals:
- National Sales – catering to domestic demand through an established network of distributors and stockists.
- International Sales – supplying branded products across multiple regulated and semi-regulated markets.
- Product Partnering – collaborating with leading Indian and foreign pharmaceutical companies.
With a broad product basket of more than 45 generics marketed under its own brands in India, the company has built a strong distribution network of over 320 distributors and stockists. On the international front, Amanta exports its branded products to 21 countries, with product registrations across 19 countries, including Africa, Latin America, the United Kingdom, and other global markets, ensuring compliance with international regulatory standards.
As of March 31, 2025, Amanta Healthcare employed 1,718 professionals across its formulation units, development centers, and quality control laboratories, reflecting its focus on innovation, regulatory compliance, and operational excellence.
Amanta Healthcare IPO – Details
| IPO Opening Date | 01 September 2025 |
| IPO Closing Date | 03 September 2025 |
| Issue Type | Book Built Issue IPO |
| Issue Size | Total Issue Size: 1,00,00,000 Shares Worth ₹126.00 Crore Fresh Issue: 1,00,00,000 Shares Worth ₹126.00 Crore |
| Face Value | ₹10 per equity share |
| IPO Price | ₹120 – ₹126 per share |
| Market Lot | 119 Shares |
| Min Order | 119 Shares [ 1 Lot ] |
| Listing At | BSE, NSE |
| Register | MUFG Intime India Pvt.Ltd. |
| QIB Shares Offered | 50% |
| NII (HNI) Shares Offered | 15% |
| Retail Shares Offered | 35% |
Amanta Healthcare IPO – Date Schedule
| IPO Open Date | 01 September 2025 |
| IPO Close Date | 03 September 2025 |
| Basis of Allotment | 04 September 2025 |
| Initiation of Refund | 05 September 2025 |
| Credit of Shares to Demat Account | 05 September 2025 |
| IPO Listing Date | 08 September 2025 |
| Cut-off time for UPI mandate confirmation | 5 PM on September 03, 2025 |
Amanta Healthcare IPO – Lots Size & Price
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 1 | 119 | ₹14,994 |
| Retail (Max) | 13 | 1,547 | ₹1,94,922 |
| S-HNI (Min) | 14 | 1,666 | ₹2,09,916 |
| S-HNI (Max) | 66 | 7,854 | ₹9,89,604 |
| B-HNI (Min) | 67 | 7,973 | ₹10,04,598 |
Competitive Strength
- Well-established manufacturer of pharmaceutical formulations with a diverse product portfolio and diverse market.
- Large manufacturing capabilities
- Wide Domestic and International Marketing Network.
- Experienced management team supported by a large, diverse and skilled workforce.
Company Promoters
- Bhavesh Patel
- Vishal Patel
- Jayshreeben Patel
- Jitendra Kumar Patel
- Milcent Appliances Private Limited
Company Financials
| Particulars | Total Revenue | Total Expense | Profit After Tax | Total Borrowing |
|---|---|---|---|---|
| 31 March 2022 | ₹262.70 Cr | ₹206.39 Cr | – ₹2.11 Cr | ₹215.66 Cr |
| 31 March 2023 | ₹281.61 Cr | ₹222.85 Cr | ₹3.63 Cr | ₹205.23 Cr |
| 31 March 2024 | ₹276.09 Cr | ₹215.04 Cr | ₹10.50 Cr | ₹195.00 Cr |
Key Performance Indicator
| KPI | Values |
|---|---|
| ROE | 12.42% |
| ROCE | 13.72% |
| Debt/Equity | 2.02 |
| RoNW | 10.89% |
| PAT Margin | 3.86% |
| EBITDA Margin | 22.11% |
| Price to Book Value | 3.77 |
| Pre IPO | Post IPO | |
| EPS (₹) | 3.64 | 2.70 |
| P/E (x) | 34.59 | 46.59 |
Object Of The Issue
| Objects of the Issue | Expected Amount (₹ in crores) |
|---|---|
| Funding capital expenditure requirements for civil construction work and towards purchase of equipment, plant and machinery for setting up new manufacturing line of SteriPort at Hariyala, Kheda, Gujarat. | ₹70.00 |
| Funding capital expenditure requirements towards civil construction work, purchase of equipment, plant and machinery for setting up new manufacturing line for SVP at Hariyala, Kheda, Gujarat. | ₹30.13 |
| General corporate purposes. |
Amanta Healthcare IPO Peer Comparison
| S. No. | Face Value (₹) | Company Name | P/E Ratio |
|---|---|---|---|
| 1 | 10 | Denis Chem Lab Limited | 15.92 |
✅Strengths
- Strong brand in IV fluids with pan-India presence.
- Diversified product portfolio and export reach.
- WHO-GMP approved modern plants.
- Experienced promoters and management team.
⚠️Risks
- Heavy reliance on IV fluids segment.
- Intense competition and price pressure.
- Regulatory compliance risks.
- Raw material price fluctuations.
- High working capital needs.
Amanta Healthcare IPO Promoter Holding
| Pre Issue Share Holding | 85.60% |
| Post Issue Share Holding | 63.56% |
Amanta Healthcare IPO Prospectus
Company Contact Information
| Amanta Healthcare Ltd. 8th Floor, Shaligram Corporates C.J. Marg Ambli, Ahmedabad, Gujarat, 380058 Phone: 079 67777600 Email: cs@amanta.co.in Website: https://www.amanta.co.in/ |
Amanta Healthcare IPO Registrar
| MUFG Intime India Pvt.Ltd. Phone: +91-22-4918 6270 Email: amantahealthcare.ipo@linkintime.co.in Website: https://linkintime.co.in/Initial_Offer/public-issues.html |
Amanta Healthcare IPO Lead Manager(s)
| 1. Beeline Capital Advisors Pvt.Ltd. |
Amanta Healthcare IPO FAQs
| What is Amanta Healthcare IPO? Amanta Healthcare IPO is a main-board IPO. The issue is priced at ₹120 to ₹126 per equity share. The IPO is to be listed on BSE & NSE. |
| When will Amanta Healthcare IPO open? The IPO is to open on 01 September 2025 for QIB, NII, and Retail Investors. |
| What is Amanta Healthcare IPO Investors Portion? The investors’ portion for QIB – 50%, NII – 15%, and Retail – 35%. |
| What is Amanta Healthcare IPO Size? Amanta Healthcare IPO size is ₹126.00 Crore. |
| What is the Amanta Healthcare IPO Minimum and Maximum Lot Size for Retail? The minimum bid is 119 Shares with ₹14,994 while the maximum bid is 1547 Shares with ₹1,94,922. |
| What is the Amanta Healthcare IPO Allotment Date? Amanta Healthcare IPO allotment date is 04 September 2025. |
| What is the Amanta Healthcare IPO Listing Date? Amanta Healthcare IPO listing date is 08 September 2025. The IPO is to be listed on BSE and NSE. |
